Streamline Your MASLD & MASH Program and Increase Your Chances of Success
The NAFLDsym® modeling software is a mechanistic, mathematical model of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD). This platform can be used to predict efficacy for treatment modalities developed for MASLD and metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH). The NAFLDsym modeling software has been utilized to evaluate a number of compounds from several large pharmaceutical companies, supporting clinical trial design optimization and clinical development decision making. Our experts leverage the NAFLDsym modeling software in proprietary services projects by performing simulations of compounds to evaluate and model their efficacy and other effects on key characteristics related to MASLD.